CCBS — Castle Creek Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Castle Creek Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -88.4 | -28.6 |
| Depreciation | ||
| Non-Cash Items | 73.1 | 0.674 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -2.56 | -4.43 |
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accounts Payable | ||
| Change in Accrued Expenses | ||
| Cash from Operating Activities | -17.8 | -31.6 |
| Capital Expenditures | -7.52 | -1.67 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | -42.1 | -23.5 |
| Acquisition of Business | ||
| Cash from Investing Activities | -49.6 | -25.2 |
| Financing Cash Flow Items | -0.922 | -0.866 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 53.5 | 20.1 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -14 | -36.7 |